UWCCC Precision Medicine Molecular Tumor Board Registry

University of Wisconsin, Madison

Summary

This study seeks to evaluate the clinical utility of the Precision Medicine Molecular Tumor Board, and to track patient outcomes.

Eligibility

Age range: 18+ years
Sex: All
Healthy volunteers: No

Detailed criteria

Inclusion Criteria: * Clinically suspected or histologically confirmed solid or hematological malignancy * Undergoing genetic testing of tumor * Ability to understand written informed consent document * Willingness to sign written informed consent document Exclusion Criteria: * Pediatric patients (age\<18 years) will be excluded due to a lack of expertise on the molecular tumor committee

Interventions

Other
PMMTB (Precision Medicine Molecular Tumor Board)
PMMTB is a clinical intervention, NOT a research intervention. The research component of this study is to observe the outcomes of the PMMTB.

Location

University of Wisconsin Carbone Cancer Center
Madison, Wisconsin
clinicaltrials@cancer.wisc.edu 800-622-8922